|
🐜
|
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study.
13 auth.
X. Pivot,
J. Gligorov,
V. Müller,
P. Barrett-Lee,
S. Verma,
A. Knoop,
G. Curigliano,
V. Semiglazov,
G. López-Vivanco,
V. Jenkins,
...
N. Scotto,
S. Osborne,
L. Fallowfield
|
7 |
2013 |
7
🐜
|
|
🐜
|
Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial.
11 auth.
A. Poveda,
F. Selle,
F. Hilpert,
A. Reuss,
A. Savarese,
I. Vergote,
...
P. Witteveen,
A. Bamias,
N. Scotto,
L. Mitchell,
E. Pujade-Lauraine
|
7 |
2015 |
7
🐜
|
|
🐜
|
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study.
92 auth.
X. Pivot,
J. Gligorov,
V. Müller,
G. Curigliano,
A. Knoop,
S. Verma,
V. Jenkins,
N. Scotto,
S. Osborne,
L. Fallowfield,
L. Fallowfield,
V. Jenkins,
J. Kilkerr,
C. Langridge,
K. Monson,
...
E. Jakobsen,
M. Nielsen,
S. Linnet,
A. Knoop,
X. Pivot,
H. Bonnefoi,
M. Mousseau,
L. Zelek,
H. Bourgeois,
C. Lefeuvre,
T. Bachelot,
T. Petit,
E. Brain,
C. Lévy,
J. Gligorov,
D. Augustin,
H. Graf,
G. Heinrich,
H. Kroening,
S. Kuemmel,
V. Müller,
F. Overkamp,
T. Park-Simon,
M. Schmidt,
L. Perlova-Griff,
C. Wolf,
M. Colleoni,
A. Ballestrero,
A. Bernardo,
A. Ribecco,
L. Gianni,
G. Curigliano,
E. Brewczyńska,
J. Jassem,
V. Shirinkin,
A. Manikhas,
V. Dvornichenko,
M. Lichinitser,
V. Semiglazov,
G. Mukhametshina,
Irina Bulavina,
E. E. Arranz,
F. Ocón,
G. L. Vivanco,
J. S. Bofill,
I. Quintela,
A. S. Muñoz,
Y. F. Pérez,
J. Espinosa,
J. Alvarez,
Rodrigo Lastra del Prado,
L. Merino,
J. P. Garcia,
S. E. Francés,
P. Edlund,
B. Norberg,
Anna-Karin Wennstig,
P. Lind,
N. Hauser,
C. Tausch,
C. Camcı,
F. Arpacı,
H. Abalı,
R. Uslu,
S. Tahir,
D. Wheatley,
Stephen E Chan,
P. Barrett-Lee,
K. McAdam,
R. Simcock,
R. Burcombe,
R. El-Maraghi,
N. Califaretti,
S. Spadafora,
S. Sehdev,
A. Sami,
S. Verma
|
7 |
2014 |
7
🐜
|
|
🐜
|
Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancer.
9 auth.
Miguel Martín,
A. Makhson,
J. Gligorov,
M. Lichinitser,
A. Lluch,
V. Semiglazov,
...
N. Scotto,
L. Mitchell,
S. Tjulandin
|
5 |
2012 |
5
🐜
|
|
🐜
|
Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer
8 auth.
J. Blum,
C. Barrios,
N. Feldman,
S. Verma,
E. McKenna,
L. Lee,
...
N. Scotto,
J. Gralow
|
5 |
2012 |
5
🐜
|
|
🐜
|
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
15 auth.
A. González Martín,
A. Oza,
A. Embleton,
J. Pfisterer,
J. Ledermann,
E. Pujade-Lauraine,
G. Kristensen,
Monique A. Bertrand,
P. Beale,
A. Cervantes,
...
E. Kent,
R. Kaplan,
M. Parmar,
N. Scotto,
T. Perren
|
5 |
2019 |
5
🐜
|
|
🐜
|
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial
22 auth.
N. Harbeck,
E. Ciruelos,
G. Jerusalem,
Volkmar Müller,
N. Niikura,
G. Viale,
Rupert Bartsch,
C. Kurzeder,
Michaela Higgins,
R. M. Connolly,
...
S. Baron-Hay,
M. Gion,
Valentina Guarneri,
G. Bianchini,
Hans Wildiers,
S. Escrivá-de-Romaní,
M. Prahladan,
Helen Bridge,
Nataliya Kuptsova-Clarkson,
N. Scotto,
Sunil Verma,
N. U. Lin
|
5 |
2024 |
5
🐜
|
|
🐜
|
Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials
8 auth.
J. Blum,
J. Kohles,
E. McKenna,
N. Scotto,
S. Hu,
D. Odom,
...
J. Kaye,
S. Glück
|
4 |
2010 |
4
🐜
|
|
🐢
|
Retrospective study to estimate the prevalence of HER2-low breast cancer (BC) and describe its clinicopathological characteristics.
12 auth.
G. Viale,
N. Niikura,
E. Tokunaga,
O. Aleynikova,
N. Hayashi,
J. Sohn,
...
C. O’Brien,
G. Higgins,
D. Varghese,
G. James,
A. Moh,
N. Scotto
|
3 |
2022 |
3
🐢
|
